Mouth may reveal leukemia fight after transplant
NCT ID NCT07271498
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 93 people who had a stem cell transplant for blood cancer. Researchers wanted to see if chronic mouth problems (oral cGVHD) could be a simple sign that the new immune system is also attacking the cancer. They followed patients with regular mouth exams before and after transplant to track this possible link.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
93 people
The number who actually took part.
- Started
-
Oct 2023
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients who received an allograft between octobre 2023 and May 2025 at CHU de Nice.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients who received an allograft between octobre 2023 and May 2025 at CHU de Nice. Exclusion Criteria: * Patients who did not received an allograft
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Allografts are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de NICE
Nice, Alpes Maritimes, 06000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.